Muscular Dystrophy

What is Muscular Dystrophy?

Muscular Dystrophy can be classified as a congenital disease consisting of missing or incorrect code for the production of an important protein known as Dystrophin. The protein is required for normal muscular functions of the body such as walking, swallowing, and coordination. There are almost 30 different forms of Muscular Dystrophy that vary in symptoms, problems and severities.  As the disease is related to muscular weakness, it can be possible that babies, teens or adults can express the muscular problems at any phase of their development. The severe form of Muscular Dystrophy is observed in babies especially boys, who can experience the swift and severe muscle wasting; dying in their late teens to early 20’s.

Treatment for Muscular Dystrophy at Cellebration Life Sciences, Inc.

Due to abnormal genetic manipulation, cells of the muscles are damaged in neuromuscular degenerative diseases such as Muscular Dystrophy.  Scientists have determined that the body has different sources of stem cells which are not being utilized. These sources of stem cells can now be extracted to isolate a rich population of stem cells which, when infused into the muscles, will replace the damaged muscle cells with healthy cells.  This can reduce the inflammation associated with Muscular Dystrophy thereby slowing the progression of the disease.

At Cellebration, we have mastered the technology for isolating the maximum number of viable stem cells from either the autologous sources of your own body or allogeneic with the matched donor to treat various patients with Muscular Dystrophy. We are a licensed, private organization with a highly technologically equipped specialized facility under development designed to isolate and enrich the viable cell stems which will be infused into the patient. Stem Cell treatment for Muscular Dystrophy involves administration of concentrated cells in the targeted area to form colonies, adapt the properties of resident stem cells and initiate some of the lost functions that have been compromised by the disease. These cells are administered through one of two methods after a considerably analysis of the patient’s unique history and medical professional’s advice.

  • Intramuscular Administration:-In this mode, cell are infused directly in the muscles.
  • Intravenous Administration:-In this mode, cells are infused through the veins to expand blood volumes in the system, to ensure that the maximum number of cells reach the targeted area.

Once infused back in the body, these cells can reach the targeted site through their strong paracrine effects and differentiate into lost muscle fiber cells or help rejuvenate the damaged cells in order to restore their function. Thus with our standardized, broad based and holistic approach, it is now possible to obtain noticeable improvements and stop the progression for patients with Muscular Dystrophy.